MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2

Michael J Coady, Abdulah El Tarazi, René Santer, Pierre Bissonnette, Louis J Sasseville, Joaquim Calado, Yoann Lussier, Christopher Dumayne, Daniel G Bichet, Jean-Yves Lapointe

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The renal proximal tubule reabsorbs 90% of the filtered glucose load through the Na(+)-coupled glucose transporter SGLT2, and specific inhibitors of SGLT2 are now available to patients with diabetes to increase urinary glucose excretion. Using expression cloning, we identified an accessory protein, 17 kDa membrane-associated protein (MAP17), that increased SGLT2 activity in RNA-injected Xenopus oocytes by two orders of magnitude. Significant stimulation of SGLT2 activity also occurred in opossum kidney cells cotransfected with SGLT2 and MAP17. Notably, transfection with MAP17 did not change the quantity of SGLT2 protein at the cell surface in either cell type. To confirm the physiologic relevance of the MAP17-SGLT2 interaction, we studied a cohort of 60 individuals with familial renal glucosuria. One patient without any identifiable mutation in the SGLT2 coding gene (SLC5A2) displayed homozygosity for a splicing mutation (c.176+1G>A) in the MAP17 coding gene (PDZK1IP1). In the proximal tubule and in other tissues, MAP17 is known to interact with PDZK1, a scaffolding protein linked to other transporters, including Na(+)/H(+) exchanger 3, and to signaling pathways, such as the A-kinase anchor protein 2/protein kinase A pathway. Thus, these results provide the basis for a more thorough characterization of SGLT2 which would include the possible effects of its inhibition on colocalized renal transporters.

Original languageEnglish
Pages (from-to)85-93
Number of pages8
JournalJournal Of The American Society Of Nephrology
Volume28
Issue number1
Early online date10 Jun 2016
DOIs
Publication statusPublished - Jan 2017

Fingerprint Dive into the research topics of 'MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2'. Together they form a unique fingerprint.

  • Cite this

    Coady, M. J., El Tarazi, A., Santer, R., Bissonnette, P., Sasseville, L. J., Calado, J., ... Lapointe, J-Y. (2017). MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2. Journal Of The American Society Of Nephrology, 28(1), 85-93. https://doi.org/10.1681/ASN.2015111282